Press Releases
May 12th, 2020
Stilla’s webinar in collaboration with Genomeweb & the National Institute of Biology, Slovenia, Thursday 11th of June 2020
Innovation in Digital PCR: Maximizing Data Output from Precious Samples by Alexandra Bogožalec Košir (National Institute of Biology, Slovenia) & Allison…
May 5th, 2020
Stilla Technologies offers a digital PCR solution to detect Covid-19 infections more sensitively and more accurately than the current RT-PCR method
Paris, May 5th, 2020 The Naica™ system, Stilla Technologies’ innovative digital PCR solution, combined with a Covid-19 detection kit, is…
April 29th, 2020
Stilla’s webinar in collaboration with Cambridge Healthtech Institute Wednesday 20th of May 2020
Highly Sensitive Crystal Digital PCRTM Detection kit for SARS-CoV-2 by Romain Parillaud, PhD (Stilla Technologies) May the 20th 2020 –…
February 25th, 2020
Stilla Technologies, Yuzi Holdings and TusPark donate digital PCR Naica™ Systems to help fight coronavirus outbreak in China
A Franco‐Chinese collaboration to better detect the virus and monitor its mutations Stilla Technologies, a leading provider of pioneering digital…
February 11th, 2020
Stilla Technologies raises €20 million ($22 million) in Series B round that brings in new investor, TUS-Holdings, alongside existing ones.
Stilla Technologies announced today that it has just raised €20 million ($22 million) in a Series B funding round that…
January 17th, 2020
Stilla’s webinar in collaboration with GenomeWeb & LGC London on Thursday 27th of February 2020
Digital PCR Method Development for Accurate Quantification of Copy Number Variationsby Alexandra Whale (LGC London) Speakers’s Bio Alexandra Whale is…
December 10th, 2019
Expansion of the Management Team at Stilla Technologies
Stilla Technologies Names Key Leadership Slate to Support Global Growth of its Next-Generation Digital PCR Solution PARIS, December 10, 2019 — Stilla…
December 4th, 2019
Stilla technologies has been picked as the Spotlight of the month by Illumina Ventures
November 2019, Article on Illuminaventures.com Our investor Illumina Ventures has featured Stilla Technologies as their monthly spotlight portfolio company.
October 23rd, 2019
Stilla’s webinar in collaboration with GenomeWeb & EMBL on Tuesday 19th of November 2019
Digital PCR for Tag Copy Number Assessment in CRISPR-Edited Cell Lines by Moritz Kueblbeck & Andrea Callegari (EMBL) Speakers’s Bio…
October 11th, 2019
Announcement of the Opening of Stilla Technologies Inc.
Stilla Technologies Opens U.S. Subsidiary for Direct Commercial Operations To Under the Leadership of Life Science Veteran Ruth Szebries Named General…